Razom, a U.S.-based nonprofit, offers support to Ukraine. The company considers itself a leader in driving point-of-care ultrasound (POCUS) training and utilization there.
To date, it already deployed more than 400 Butterfly iQ+ handheld ultrasound devices in the country. The expansion of this partnership with Butterfly Network brings an additional 200 of those devices to the frontlines.
Butterfly IQ+, a transducer system, uses semiconductor technology to perform whole-body imaging using a single handheld probe. The company’s proprietary Ultrasound-on-Chip technology powers the system. It connects to a mobile device and uses AI to deliver advanced imaging.
“At Butterfly, improving access to ultrasound technology in austere, under-resourced or emergency settings is core to our mission. We are proud to work with partners like Razom who share our commitment to not only deploying technology but driving adoption and usage of POCUS through education and training,” Joseph DeVivo, president, CEO and chair of Butterfly Network, said in a news release. “Through these partnerships, our advanced imaging technology and ultrasound education materials reach the places that need it most worldwide.”
Butterfly Network has deployed nearly 900 of its devices in Ukraine through more than 40 global health partnerships since 2022. The company has executed similar programs in Kenya as well.
“The Butterfly iQ+ probe, renowned for its comprehensive whole-body assessment capabilities, is incredibly compact and lightweight, making it the perfect tool for medics and first responders to carry into the field,” said Dan Solchanyk, Razom Health program director. “Moreover, it’s invaluable for performing routine prenatal and primary care services within survival shelters. This partnership symbolizes our commitment to enhancing healthcare accessibility and quality in Ukraine, even under the most challenging circumstances.”
